Boston-based personalized health improvement technology maker Healthrageous received Series B financing from Partners Innovation Fund, part of Partners HealthCare.
The new funds complete Parters’ incubation role, Healthrageous reported.
The Partners Innovation Fund was launched with a $35 million investment from Brigham and Women’s Hospital and Massachusetts General Hospital. It provides funding for early-stage technology to advance innovations in medical systems, therapy, drugs and medical devices, according to the press release.
“Our investment in Healthrageous is a prime example of Partners’ goal to take medical innovations discovered by our researchers and provide the appropriate support and infrastructure to allow technology development, commercialization and, ultimately, the development of products to benefit patients," CFO Peter Markell Partners HealthCare said in prepared remarks. “We believe Healthrageous can have a tremendous impact on improving individual behaviors that lead to better management and outcomes of costly chronic diseases, like hypertension."
Healthrageous in 2010 raised $6 million in a Series A equity sale, which was led by North Bridge Venture Partners of Boston and joined by fellow Boston-based firm Egan Managed Capital and Long River Ventures of Amherst, Mass.
Previous studies have showed that a web-based self-management program featuring personalized goal-setting and health journey maps with gaming dynamics helped 404 employees with prehypertension or hypertension achieve lower blood pressure and improve communication with their doctors, according to the press release.
About 76.4 million people over age 20 in the U.S. have been diagnosed with high blood pressure and the patients enrolled in the company’s hypertension self-management program over the past 18 months showed a sustained engagement rate of 70%, Healthrageous said.
